Acne in Patients with Skin of Color: Medical & Procedural Treatment Strategies
The 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC, and Dr. Andrew Alexis, Professor of Clinical Dermatology …
The 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC, and Dr. Andrew Alexis, Professor of Clinical Dermatology … Continue reading "Acne in Patients with Skin of Color: Medical & Procedural Treatment Strategies"
Explore the February 2024 issue of the Journal of Drugs in Dermatology! Discover groundbreaking research on topics such as novel treatments for melasma, advancements in psoriasis management, gene expression profile (GEP) testing for squamous cell carcinoma, pediatric vitiligo, and many more! Stay ahead of the curve with the latest insights from leading dermatology experts. Straight from the Editor … 
The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl … 
We have probably all seen a patient with rosacea. After all, it is quite common in middle-aged, fair-skinned women. Here, however, we will explore a talk given by Dr. Hilary Baldwin (Medical director of the Acne Treatment & Research Center in Morristown, NJ and Brooklyn, NY, and Clinical Associate Professor of Dermatology at Rutgers Robert Wood Johnson Medical Center) at the 2022 Skin of Color … 
2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used prominently in acne vulgaris, and is also employed in many other dermatological conditions because of its molecular and pharmacological properties. In this article, we review the history of minocycli … 